Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,320 papers from all fields of science
Search
Sign In
Create Free Account
deoxythymidine diphosphate-oleandrose
Known as:
dTDP-oleandrose
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Hexoses
Thymine Nucleotides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The asymmetric syntheses of methyl D-digitoxoside, L-oleandrose and L-cymarose from methyl sorbate, an achiral precursor.
M. Ono
,
X. Zhao
,
Keisuke Kato
,
H. Akita
Chemical and pharmaceutical bulletin
2012
Corpus ID: 4240754
The addition of 4 eq of chloral to osmundalactone (4S,5R)-4 gave quantitative formation of the hemiacetal derivative (4S,5R)-8…
Expand
2006
2006
Total Synthesis of L-Oleandrose and L-Cymarose from an Achiral Precursor, Methyl Sorbata
Xi
,
Ying
,
+7 authors
Chi
2006
Corpus ID: 92724971
2,6-Dideoxy sugars L-oleandrose 1 and L-cymarose 2, the key carbohydrate of antibiotics and cardiac glycosides, were synthesized…
Expand
1994
1994
Correlation of the Avermectin Polyketide Synthase Genes to the Avermectin Structure: Implications for Designing Novel Avermectins
D. Macneil
,
J. Occi
,
K. Gewain
,
T. Macneil
Annals of the New York Academy of Sciences
1994
Corpus ID: 31028658
Streptomyces avermitilis produces a series of eight potent anthelmintic compounds called avermectins (AVM). AVM are pentacyclic…
Expand
1993
1993
Deletion analysis of the avermectin biosynthetic genes of Streptomyces avermitilis by gene cluster displacement
T. Macneil
,
K. Gewain
,
D. Macneil
Journal of Bacteriology
1993
Corpus ID: 28783372
Streptomyces avermitilis produces a group of glycosylated, methylated macrocyclic lactones, the avermectins, which have potent…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE